<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fallahi-Sichani, M.</style></author><author><style face="normal" font="default" size="100%">Flynn, J.A.L.</style></author><author><style face="normal" font="default" size="100%">Linderman, J.J.</style></author><author><style face="normal" font="default" size="100%">Kirschner, D.E.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of Immunology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/22379032</style></url></web-urls></urls><publisher><style face="normal" font="default" size="100%">Am Assoc Immnol</style></publisher><volume><style face="normal" font="default" size="100%">188</style></volume><pages><style face="normal" font="default" size="100%">3169-78</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">7</style></issue></record></records></xml>